TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $234,642 | -54.5% | 478,862 | -58.7% | 0.00% | -50.0% |
| Q4 2022 | $515,762 | -36.8% | 1,159,016 | -3.1% | 0.01% | -40.0% |
| Q3 2022 | $816,000 | -64.4% | 1,196,463 | -57.6% | 0.01% | -61.5% |
| Q2 2022 | $2,290,000 | -56.5% | 2,820,073 | -24.5% | 0.03% | -43.5% |
| Q1 2022 | $5,267,000 | -73.3% | 3,735,237 | -24.0% | 0.05% | -70.9% |
| Q4 2021 | $19,710,000 | -46.5% | 4,915,239 | -16.6% | 0.16% | -45.1% |
| Q3 2021 | $36,836,000 | +12.7% | 5,893,876 | +0.4% | 0.29% | +17.1% |
| Q2 2021 | $32,690,000 | -57.6% | 5,871,925 | -2.2% | 0.25% | -57.4% |
| Q1 2021 | $77,125,000 | – | 6,001,971 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,095,534 | 0.06% |
| Baker Brothers Advisors | 7,624,835 | $3,736,169 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 223,934 | $109,728 | 0.01% |
| ArrowMark Colorado Holdings LLC | 478,862 | $234,642 | 0.00% |
| WELLS FARGO & COMPANY/MN | 167 | $82 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,652 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 144,416 | $70,763 | 0.00% |
| STATE STREET CORP | 49,536 | $24,273 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 163,663 | $80 | 0.00% |